Literature DB >> 3051021

Development of human tumor cell line panels for use in disease-oriented drug screening.

R H Shoemaker1, A Monks, M C Alley, D A Scudiero, D L Fine, T L McLemore, B J Abbott, K D Paull, J G Mayo, M R Boyd.   

Abstract

Entities:  

Mesh：

Year:  1988        PMID： 3051021

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN： 0361-7742


× No keyword cloud information.
  38 in total

1.  Basic principles in preclinical cancer chemotherapy.

Authors:  N Brock; J Pohl; B Schneider
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

2.  Drug discovery: Cell lines battle cancer.

Authors:  John N Weinstein
Journal:  Nature       Date:  2012-03-28       Impact factor: 49.962

3.  Antiproliferative mechanisms of action of the flavin dehydrogenase inhibitors diphenylene iodonium and di-2-thienyliodonium based on molecular profiling of the NCI-60 human tumor cell panel.

Authors:  James H Doroshow; Agnes Juhasz; Yun Ge; Susan Holbeck; Jiamo Lu; Smitha Antony; Yongzhong Wu; Guojian Jiang; Krishnendu Roy
Journal:  Biochem Pharmacol       Date:  2012-01-24       Impact factor: 5.858

4.  Cancer: Discrepancies in drug sensitivity.

Authors:  John N Weinstein; Philip L Lorenzi
Journal:  Nature       Date:  2013-11-27       Impact factor: 49.962

5.  Integrating data on DNA copy number with gene expression levels and drug sensitivities in the NCI-60 cell line panel.

Authors:  Kimberly J Bussey; Koei Chin; Samir Lababidi; Mark Reimers; William C Reinhold; Wen-Lin Kuo; Fuad Gwadry; Hosein Kouros-Mehr; Jane Fridlyand; Ajay Jain; Colin Collins; Satoshi Nishizuka; Giovanni Tonon; Anna Roschke; Kristen Gehlhaus; Ilan Kirsch; Dominic A Scudiero; Joe W Gray; John N Weinstein
Journal:  Mol Cancer Ther       Date:  2006-04       Impact factor: 6.261

6.  Exploiting genetic complexity in cancer to improve therapeutic strategies.

Authors:  Mathew J Garnett; Ultan McDermott
Journal:  Drug Discov Today       Date:  2012-02-08       Impact factor: 7.851

7.  Phase II study of 4-ipomeanol, a naturally occurring alkylating furan, in patients with advanced hepatocellular carcinoma.

Authors:  S Lakhanpal; R C Donehower; E K Rowinsky
Journal:  Invest New Drugs       Date:  2001       Impact factor: 3.850

8.  Drug-eluting microarrays to identify effective chemotherapeutic combinations targeting patient-derived cancer stem cells.

Authors:  Matthew R Carstens; Robert C Fisher; Abhinav P Acharya; Elizabeth A Butterworth; Edward Scott; Emina H Huang; Benjamin G Keselowsky
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-29       Impact factor: 11.205

Review 9.  Integrating phenotypic small-molecule profiling and human genetics: the next phase in drug discovery.

Authors:  Cory M Johannessen; Paul A Clemons; Bridget K Wagner
Journal:  Trends Genet       Date:  2014-12-12       Impact factor: 11.639

10.  Chromosomal instability is associated with higher expression of genes implicated in epithelial-mesenchymal transition, cancer invasiveness, and metastasis and with lower expression of genes involved in cell cycle checkpoints, DNA repair, and chromatin maintenance.

Authors:  Anna V Roschke; Oleg K Glebov; Samir Lababidi; Kristen S Gehlhaus; John N Weinstein; Ilan R Kirsch
Journal:  Neoplasia       Date:  2008-11       Impact factor: 5.715
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.